About: SARS-Cov-2 RNA Found on Particulate Matter of Bergamo in Northern Italy: First Preliminary Evidence

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: SARS-Cov-2 RNA Found on Particulate Matter of Bergamo in Northern Italy: First Preliminary Evidence Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	SARS-Cov-2 RNA Found on Particulate Matter of Bergamo in Northern Italy: First Preliminary Evidence
Creator	Pallavicini, Alberto Barbieri, Pierluigi Borelli, Massimo De Gennaro, Gianluigi Miani, Alessandro Palmisani, Jolanda Passarini, Fabrizio Perrone, Maria Piscitelli, Prisco Ruscio, Maurizio Setti, Leonardo Torboli, Valentina Gilio, Alessia
Source	MedRxiv
abstract	In previous communications, we have hypothesized the possibility that SARS-CoV-2 virus could be present on particulate matter (PM) during the spreading of the infection, consistently with evidence already available for other viruses. Here, we present the first results of the analyses that we have performed on 34 PM10 samples of outdoor/airborne PM10 from an industrial site of Bergamo Province, collected with two different air samplers over a continuous 3-weeks period, from February 21st to March 13th. We can confirm to have reasonably demonstrated the presence of SARS-CoV-2 viral RNA by detecting highly specific RtDR gene on 8 filters in two parallel PCR analyses. This is the first preliminary evidence that SARS-CoV-2 RNA can be present on outdoor particulate matter, thus suggesting that, in conditions of atmospheric stability and high concentrations of PM, SARS-CoV-2 could create clusters with outdoor PM and, by reducing their diffusion coefficient, enhance the persistence of the virus in the atmosphere. Further confirmations of this preliminary evidence are ongoing, and should include real-time assessment about the vitality of the SARS-CoV-2 as well as its virulence when adsorbed on particulate matter. At the present, no assumptions can be made concerning the correlation between the presence of the virus on PM and COVID-19 outbreak progression. Other issues to be specifically addressed are the average concentrations of PM eventually required for a potential boost effect of the contagion (in case it is confirmed that PM might act as a carrier for the viral droplet nuclei), or even the theoretic possibility of immunization consequent to minimal dose exposures at lower thresholds of PM.
has issue date	2020-04-18(xsd:dateTime)
bibo:doi	10.1101/2020.04.15.20065995
has license	medrxiv
sha1sum (hex)	8c791e5296024ab05564750b9bf14d7e55f036d0
schema:url	https://doi.org/10.1101/2020.04.15.20065995
resource representing a document's title	SARS-Cov-2 RNA Found on Particulate Matter of Bergamo in Northern Italy: First Preliminary Evidence
resource representing a document's body	covid:8c791e5296024ab05564750b9bf14d7e55f036d0#body_text
is schema:about of	named entity 'Letter to the Editor' named entity 'Bergamo' named entity 'Particulate Matter' named entity 'virus' named entity 'soil microbe' named entity 'quartz' named entity 'Italian' named entity 'virulence' named entity 'PM10' named entity '1 ml' named entity 'gene' named entity 'medRxiv' named entity 'COVID-19 outbreak' named entity 'RNA' named entity 'SARS-CoV-2' named entity 'molecular marker' named entity '99.9%' named entity 'SARS-CoV-2' named entity 'Particulate matter' named entity 'aerosol' named entity 'gene' named entity 'adsorbed' named entity 'PM10' named entity 'viruses' named entity 'mortality rates' named entity 'immunization' named entity 'reference method' named entity 'SARS-CoV-2' named entity 'DNA polymerases' named entity 'medRxiv' named entity 'CC-BY-NC-ND 4.0' named entity 'extraction of RNA' named entity 'particulate matter' named entity 'SARS-CoV-2' named entity 'U.S.' named entity 'molecular marker' named entity 'molecular genetic' named entity 'viral RNA' named entity 'nuclei' named entity 'diagnostic tests' named entity 'RNA' named entity 'particulate matter' named entity 'COVID-19' named entity 'RdRP' named entity 'clinical laboratory' named entity 'SARS-CoV-2' named entity 'RNA' named entity 'SARS-CoV-2' named entity 'medRxiv' named entity 'SARS-CoV-2' named entity 'microbiome' named entity 'infection' named entity 'virus' named entity 'CC-BY-NC-ND 4.0' named entity 'polypropylene' named entity 'SARS-CoV-2' named entity 'blind test' named entity 'environmental pollution' named entity 'RNAs' named entity 'particulate matter' named entity 'peer review' named entity 'Bergamo Province' named entity 'Harvard School of Public Health' named entity 'diffusion' named entity 'particulate matter' named entity 'PM10' named entity 'SARS-CoV-2' named entity 'medRxiv' named entity 'Italian' named entity 'RNA' named entity 'gene' named entity 'virus' named entity 'gene'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software